News

Filter

126 to 135 of 95870 results

FDA fast tracks CTI BioPharma's pacritinib for myelofibrosis

FDA fast tracks CTI BioPharma's pacritinib for myelofibrosis

08-08-2014

US biotech firm CTI BioPharma (formerly called Cell Therapeutics) says that its pacritinib has been granted…

CTI BioPharmaOncologypacritinibPharmaceuticalRegulationUSA

MS market to reach $20 billion in 2023 boosted by five new therapies

MS market to reach $20 billion in 2023 boosted by five new therapies

08-08-2014

The forecast launch of five immunomodulatory therapies for relapsing forms of multiple sclerosis will…

CNS DiseasesEuropeImmunosuppressantsJapanMarkets & MarketingMSPharmaceuticalUSA

Australia pledges funding to find dementia breakthrough

Australia pledges funding to find dementia breakthrough

08-08-2014

The Australian Minister for Health, Peter Dutton, has announced the opening of a new round of dementia…

AustraliaCognitive disordersDementiaNeurologicalPharmaceuticalResearch

Clinigen backs white paper calling for recognition of early access schemes

Clinigen backs white paper calling for recognition of early access schemes

08-08-2014

UK-based Clinigen Group has published a new International Society for Pharmaceutical Engineering (ISPE)…

Clinigen GroupHealthcarePharmaceuticalRegulationUKUnited States

Added benefit of Novo Nordisk’s Tresiba not proven, says IQWiG

Added benefit of Novo Nordisk’s Tresiba not proven, says IQWiG

08-08-2014

In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

DiabetesGerman Institute for Quality and EfficiencyGermanyNovo NordiskPharmaceuticalPricingRegulationTresiba

IQWiG finds no added benefit for Biogen Idec’s Tecfidera

IQWiG finds no added benefit for Biogen Idec’s Tecfidera

08-08-2014

In its early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG)…

Biogen IdecBiotechnologyGermanyMSNeurologicalPricingRegulationTecfidera

Baxter opens its first state-of-the-art biologics facility in Asia

Baxter opens its first state-of-the-art biologics facility in Asia

08-08-2014

US drugmaker Baxter International has formally opened its S$370 million ($297 million) first advanced…

AdvateBaxter InternationalBiotechnologyEuropean Medicines AgencyHematologyHemophilia BProductionSingapore

OX-MPI project returned to Orexo

OX-MPI project returned to Orexo

08-08-2014

Swedish drug developer Orexo says that German family-owned pharma major Boehringer Ingelheim has decided…

Boehringer IngelheimGermanyLicensingOrexo ABPharmaceuticalProstaglandin ESweden

Teva to sue Dr Reddy’s over Copaxone patent infringement

Teva to sue Dr Reddy’s over Copaxone patent infringement

08-08-2014

Global generics leader Teva Pharmaceutical Industries yesterday confirmed that it has received the first…

CopaxoneDr Reddy's LaboratoriesLegalNeurologicalPatentsPharmaceuticalTeva Pharmaceutical IndustriesUSA

126 to 135 of 95870 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top